Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan · Delayed Price · Currency is TWD 126.50
+2.00 (1.61%)
Nov 6, 2026, 1:30 PM CST
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 10.72 billion as of November 6, 2026. It is the 17,242nd most valuable company in the world and the 626th biggest in Taiwan. Its market cap has decreased by 9.64% in one year.
Market Cap
10.72B
Enterprise Value
11.23B
Revenue
4.27B
Global Rank
Country Rank
#626 Taiwan
PE Ratio
9.40
ChartMarket Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 10.72B, an increase of 965.99%. That is a compound annual growth rate of 14.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 10.72B | -13.36% |
| Dec 31, 2025 | 12.37B | -27.00% |
| Dec 31, 2024 | 16.94B | -27.80% |
| Dec 29, 2023 | 23.47B | -1.63% |
| Dec 30, 2022 | 23.86B | 10.75% |
| Dec 30, 2021 | 21.54B | 18.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 501.46B |
| Lin BioScience | 130.60B |
| Caliway Biopharmaceuticals | 103.59B |
| Heron Neutron Medical | 64.86B |
| ACRO Biomedical | 12.44B |
| Grape King Bio | 12.37B |
| Lumosa Therapeutics | 12.11B |
| Vizionfocus | 11.98B |